Back to
Citadel Advisors LLC
AURA
Showing 8 of 19 quarters
Position history for
Citadel Advisors LLC's holdings in Aura Biosciences, Inc.
Yes. Citadel Advisors holds 51,902 shares of AURA (Aura Biosciences), worth $368,504, as of its Q2 2026 13F filing. It increased the position from 12,503 shares in Q1 2026. Citadel Advisors has held AURA since Q4 2025, across 3 quarterly 13F filings.
Current Value
$368,504
Current Shares
51,902
Total Value Change
+$359,496
Total Shares Change
+50,891
Quarter-by-Quarter History
Other major holders of AURA: Adage Capital Partners GP, L.L.C.